Dysfunction of glutamate neurotransmission in the nucleus accumbens (NAc) has been implicated in the pathophysiology of alcohol use disorders (AUD). Neurogranin (Ng) is exclusively expressed in the brain and mediates N-methyl-D-aspartate receptor (NMDAR) hypo-function by regulating the intracellular calcium-calmodulin (Ca 2+ -CaM) pathway. Interestingly, Ng null mice (Ng -/mice) demonstrate increased alcohol drinking compared to wild-type mice, while also showing less tolerance to the effect of alcohol. To identify the molecular mechanism related to alcohol seeking, we utilized both in vivo microdialysis and label-free quantification proteomics comparing Ng genotype and effects of alcohol treatment on the NAc. There is significant difference in glutamate and GABA neurotransmission between genotypes, however, alcohol administration normalizes both glutamate and GABA levels in the NAc. Using label-free proteomics, we identified 427 protein expression changes against alcohol treatment in the NAc among 4,347 total proteins detected. Bioinformatics analyses revealed significant molecular differences in Ng null mice in response to acute alcohol treatment. Ingenuity pathway analysis found that the AKT network was altered significantly between genotypes, which might increase the sensitivity of alcohol in Ng null mice. Finally, our pharmacoproteomics results illustrate a possible molecular basis for the NAc-mediated alcohol seeking, which provides a better understanding of the Ngmediated signaling in AUD.